Adaptive Coping Skills Training to Improve Psychological Distress Among Cardiorespiratory Failure Survivors
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Duke University
- Study ID
- NCT06538246
- Status
- Recruiting
Conditions
- Anxiety
- Breath Shortness
- Depression
- Post-traumatic Stress Disorder
- Stress
- Worries; Pain or Disability
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Blueprint — BEHAVIORALThis is a mobile app-based adaptive coping skills intervention that lasts 1 month
- Education program — BEHAVIORALThis is a mobile app-based education program that lasts 1 month
Study Details
Conditions treated in intensive care units (ICUs) such as the acute respiratory distress syndrome (ARDS), congestive heart failure, COVID pneumonia, and sepsis are common. These can lead to high rates of depression, anxiety, and PTSD that worsen quality of life. Yet there are few effective strategies able to overcome barriers of limited access to mental health care. Even less is known about the experiences of patients from racially and ethnically minoritized populations because of they haven't been included well in past research. To address this problem, the investigators developed Blueprint, a mobile app that coaches people to use adaptive coping skills to self-manage their symptoms. The investigators found that it reduced depression symptoms and improved quality of life compared to placebo. To confirm these promising findings, the investigators are doing a formal test of Blueprint. The investigators will enroll 400 people who received ICU care from 4 hospitals (Duke, UCLA, Colorado, and Oregon). These patients will be randomized to receive either the Blueprint mobile app or a special Education Program mobile app the investigators developed. -both delivered through similar mobile app platforms. Our specific aims are to see which program improves symptoms better across 6 months of follow up. This project addresses national research priorities and could advance the field with a personalizable yet population-focused therapy that could be scaled broadly and efficiently to enhance mental health equity.
Key Dates
- Start date
- Oct 15, 2024
- Status verified
- Mar 2026
- Primary completion
- Nov 15, 2027
- Completion
- Apr 15, 2028
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Blueprint adaptive coping skills interventionThis is a unique adaptive coping skills intervention developed over years of research that targets patients hospitalized for cardiorespiratory conditions. Participants will receive 4 weeks of different Blueprint content through a mobile app. Each week's session includes a within-app HADS survey for safety monitoring. A printed or PDF workbook with complementary content and QR links to app videos is provided.
- Active Comparator: Education program controlThis is cardiorespiratory condition-specific content through an iterative process, informed by research on informational needs and past successful education programs. Participants will receive 4 weeks of different 10-minute informational videos unrelated to Blueprint content through a mobile app. Each week's session includes a within-app HADS survey for safety monitoring. A printed or PDF workbook with complementary content and QR links to app videos is provided.
Primary Outcome Measure
Hospital Anxiety and Depression Scale (HADS) [ Time Frame: Baseline, 1 month, 3 months, and 6 months post-randomization ]
Central Contacts
- Christopher Cox919-681-7232
- Kristy Johnson
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke University Medical Center | Durham | North Carolina | 27710 | Kristy Johnson Christopher Cox, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Durham, NC
Related Studies
- Retinal Imaging in Neurodegenerative DiseaseRecruiting · Duke University · Durham, North Carolina
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.PHASE3 · Recruiting · AbbVie · Bentonville, Arkansas
- Examining the Effects of Estradiol on Neural and Molecular Response to RewardPHASE4 · Recruiting · University of North Carolina, Chapel Hill · Chapel Hill, North Carolina
- Wellness App for Sleep Disturbance in Hematological Cancer PatientsRecruiting · The University of Texas Health Science Center at San Antonio · Phoenix, Arizona